Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joanne Milot

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Chest|December 12, 2002
How should we quantify asthma control? A proposalLouis-Philippe Boulet, Véronique Boulet, Joanne Milot
International Journal of Chronic Obstructive Pulmonary Disease|March 19, 2019
Longitudinal comparison of outcomes in patients with smoking-related asthma-COPD overlap and in non-smoking asthmatics with incomplete reversibility of airway obstructionLouis-Philippe Boulet, Marie-Eve Boulay, Joanne Milot, et al.
Respiratory Medicine|March 26, 2017
Comparative prevalence of co-morbidities in smoking and non-smoking asthma patients with incomplete reversibility of airway obstruction, non-smoking asthma patients with complete reversibility of airway obstruction and COPD patientsMyriam Nadeau, Marie-Ève Boulay, Joanne Milot, et al.
COPD|April 24, 2018
Asthma-COPD Overlap Phenotypes and Smoking :Comparative features of asthma in smoking or non-smoking patients with an incomplete reversibility of airway obstructionLouis-Philippe Boulet, Marie-Ève Boulay, Jude-Lyne Dérival, et al.
Respiration; International Review of Thoracic Diseases|December 8, 2020
Asthma with Irreversible Airway Obstruction in Smokers and Nonsmokers: Links between Airway Inflammation and Structural ChangesLouis-Philippe Boulet, Marie-Eve Boulay, Harvey O Coxson, et al.
American Journal of Respiratory and Critical Care Medicine|August 21, 2002
Diisocyanate antigen-stimulated monocyte chemoattractant protein-1 synthesis has greater test efficiency than specific antibodies for identification of diisocyanate asthmaDavid I Bernstein, André Cartier, Johanne Côté, et al.
Pulmonary Pharmacology & Therapeutics|September 19, 2016
The effects of a CXCR1/CXCR2 antagonist on neutrophil migration in mild atopic asthmatic subjectsCandice M Todd, Brittany M Salter, Desmond M Murphy, et al.
Respiratory Research|October 28, 2011
Roflumilast attenuates allergen-induced inflammation in mild asthmatic subjectsGail M Gauvreau, Louis-Philippe Boulet, Christine Schmid-Wirlitsch, et al.
The Journal of Allergy and Clinical Immunology|December 17, 2009
Prolonged bronchoprotection against inhaled methacholine by inhaled BI 1744, a long-acting beta(2)-agonist, in patients with mild asthmaPaul M O'Byrne, Just van der Linde, Donald W Cockcroft, et al.
The Journal of Allergy and Clinical Immunology|May 18, 2016
Efficacy and safety of multiple doses of QGE031 (ligelizumab) versus omalizumab and placebo in inhibiting allergen-induced early asthmatic responsesGail M Gauvreau, Jonathan P Arm, Louis-Philippe Boulet, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Chest|December 12, 2002
How should we quantify asthma control? A proposalLouis-Philippe Boulet, Véronique Boulet, Joanne Milot
International Journal of Chronic Obstructive Pulmonary Disease|March 19, 2019
Longitudinal comparison of outcomes in patients with smoking-related asthma-COPD overlap and in non-smoking asthmatics with incomplete reversibility of airway obstructionLouis-Philippe Boulet, Marie-Eve Boulay, Joanne Milot, et al.
Respiratory Medicine|March 26, 2017
Comparative prevalence of co-morbidities in smoking and non-smoking asthma patients with incomplete reversibility of airway obstruction, non-smoking asthma patients with complete reversibility of airway obstruction and COPD patientsMyriam Nadeau, Marie-Ève Boulay, Joanne Milot, et al.
COPD|April 24, 2018
Asthma-COPD Overlap Phenotypes and Smoking :Comparative features of asthma in smoking or non-smoking patients with an incomplete reversibility of airway obstructionLouis-Philippe Boulet, Marie-Ève Boulay, Jude-Lyne Dérival, et al.
Respiration; International Review of Thoracic Diseases|December 8, 2020
Asthma with Irreversible Airway Obstruction in Smokers and Nonsmokers: Links between Airway Inflammation and Structural ChangesLouis-Philippe Boulet, Marie-Eve Boulay, Harvey O Coxson, et al.
American Journal of Respiratory and Critical Care Medicine|August 21, 2002
Diisocyanate antigen-stimulated monocyte chemoattractant protein-1 synthesis has greater test efficiency than specific antibodies for identification of diisocyanate asthmaDavid I Bernstein, André Cartier, Johanne Côté, et al.
Pulmonary Pharmacology & Therapeutics|September 19, 2016
The effects of a CXCR1/CXCR2 antagonist on neutrophil migration in mild atopic asthmatic subjectsCandice M Todd, Brittany M Salter, Desmond M Murphy, et al.
Respiratory Research|October 28, 2011
Roflumilast attenuates allergen-induced inflammation in mild asthmatic subjectsGail M Gauvreau, Louis-Philippe Boulet, Christine Schmid-Wirlitsch, et al.
The Journal of Allergy and Clinical Immunology|December 17, 2009
Prolonged bronchoprotection against inhaled methacholine by inhaled BI 1744, a long-acting beta(2)-agonist, in patients with mild asthmaPaul M O'Byrne, Just van der Linde, Donald W Cockcroft, et al.
The Journal of Allergy and Clinical Immunology|May 18, 2016
Efficacy and safety of multiple doses of QGE031 (ligelizumab) versus omalizumab and placebo in inhibiting allergen-induced early asthmatic responsesGail M Gauvreau, Jonathan P Arm, Louis-Philippe Boulet, et al.
Pageof 1